1. Home
  2. BGLC vs NCRA Comparison

BGLC vs NCRA Comparison

Compare BGLC & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$2.14

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Logo Nocera Inc.

NCRA

Nocera Inc.

HOLD

Current Price

$0.20

Market Cap

5.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGLC
NCRA
Founded
2017
2002
Country
Malaysia
Taiwan
Employees
N/A
N/A
Industry
Medical Specialities
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
5.2M
5.6M
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
BGLC
NCRA
Price
$2.14
$0.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.1K
586.4K
Earning Date
04-14-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
45.78
N/A
EPS
N/A
N/A
Revenue
$7,424,911.00
$13,627,944.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.92
$0.17
52 Week High
$15.19
$2.40

Technical Indicators

Market Signals
Indicator
BGLC
NCRA
Relative Strength Index (RSI) 40.46 34.44
Support Level $2.14 $0.18
Resistance Level $2.73 $0.24
Average True Range (ATR) 0.06 0.03
MACD 0.00 0.01
Stochastic Oscillator 0.00 43.23

Price Performance

Historical Comparison
BGLC
NCRA

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

Share on Social Networks: